Skip to main content

Open Radical Retropubic Prostatectomy

  • Chapter
  • First Online:
Radical Prostatectomy

Abstract

Radical prostatectomy (RP) is the mainstay of treatment for patients with clinically localized prostate cancer, especially for those patients with high-risk cancer. Large multi-institutional studies have documented excellent long-term outcomes in terms of biochemical recurrence rates and prostate cancer-specific mortality after RP. Proper preoperative planning begins with selecting patients who have potentially lethal cancers and are likely to benefit from surgery, and in whom RP is reasonably likely to remove the entire tumor. Magnetic resonance imaging (MRI) is used to delineate the anatomic details of the prostate and of the cancer, and can assist in customizing the operation, particularly in regard to nerve sparing. Oncologic and functional outcomes are highly dependent on surgical technique and on the surgeon’s level of experience. In our experience, early release of the neurovascular bundles, full preservation of urethral length, complete excision of the seminal vesicles, and wide dissection with careful reconstruction of the bladder neck are key components to optimal cancer control and recovery of sexual and urinary function. In this chapter, we provide a detailed description of our approach to retropubic RP.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

RP:

Radical prostatectomy

PSA:

Prostate-specific antigen

DRE:

Digital rectal examination

PLND:

Pelvic lymph node dissection

NVB:

Neurovascular bundle

BCR:

Biochemical recurrence

PCSM:

Prostate cancer specific mortality

References

  1. Millin T. Retropubic prostatectomy. J Urol. 1948;59(3):267–80. PubMed PMID: 18903535.

    PubMed  CAS  Google Scholar 

  2. Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell-Walsh Urology. 10th ed. Saint Louis, MO: Saunders; 2011. p. 5688.

    Google Scholar 

  3. Begg CB, Riedel ER, Bach PB, Kattan MW, Schrag D, Warren JL, et al. Variations in morbidity after radical prostatectomy. N Engl J Med. 2002;346(15):1138–44. PubMed PMID: 11948274.

    Article  PubMed  Google Scholar 

  4. Bianco Jr FJ, Vickers AJ, Cronin AM, Klein EA, Eastham JA, Pontes JE, et al. Variations among experienced surgeons in cancer control after open radical prostatectomy. J Urol. 2010;183(3):977–82. PubMed PMID: 20083278. Pubmed Central PMCID: 3244752.

    Article  PubMed  Google Scholar 

  5. Catalona WJ, Carvalhal GF, Mager DE, Smith DS. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol. 1999;162(2):433–8. PubMed PMID: 10411052.

    Article  PubMed  CAS  Google Scholar 

  6. Maffezzini M, Seveso M, Taverna G, Giusti G, Benetti A, Graziotti P. Evaluation of complications and results in a contemporary series of 300 consecutive radical retropubic prostatectomies with the anatomic approach at a single institution. Urology. 2003;61(5):982–6. PubMed PMID: 12736020.

    Article  PubMed  Google Scholar 

  7. Coakley FV, Eberhardt S, Kattan MW, Wei DC, Scardino PT, Hricak H. Urinary continence after radical retropubic prostatectomy: relationship with membranous urethral length on preoperative endorectal magnetic resonance imaging. J Urol. 2002;168(3):1032–5. PubMed PMID: 12187216.

    Article  PubMed  Google Scholar 

  8. Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, et al. Prostate specific antigen best practice statement: 2009 update. J Urol. 2013;189(1 Suppl):S2–11. PubMed PMID: 23234625.

    Article  PubMed  Google Scholar 

  9. Levran Z, Gonzalez JA, Diokno AC, Jafri SZ, Steinert BW. Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer? Br J Urol. 1995;75(6):778–81. PubMed PMID: 7542138.

    Article  PubMed  CAS  Google Scholar 

  10. Messing EM, Manola J, Yao J, Kiernan M, Crawford D, Wilding G, et al. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Lancet Oncol. 2006;7(6):472–9. PubMed PMID: 16750497. Epub 2006/06/06. eng.

    Article  PubMed  CAS  Google Scholar 

  11. Masterson TA, Bianco Jr FJ, Vickers AJ, DiBlasio CJ, Fearn PA, Rabbani F, et al. The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. J Urol. 2006;175(4):1320–4. PubMed PMID: 16515989. Pubmed Central PMCID: PMC1950746. discussion 4–5. Epub 2006/03/07. eng.

    Article  PubMed  Google Scholar 

  12. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am. 2001;28(3):555–65.

    Article  PubMed  CAS  Google Scholar 

  13. Schumacher MC, Burkhard FC, Thalmann GN, Fleischmann A, Studer UE. Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Eur Urol. 2008;54(2):344–52. PubMed PMID: 18511183. Epub 2008/05/31. eng.

    Article  PubMed  Google Scholar 

  14. Briganti A, Chun FK, Salonia A, Zanni G, Scattoni V, Valiquette L, et al. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol. 2006;49(6):1019–26. PubMed PMID: 16530933. discussion 26–7. Epub 2006/03/15. eng.

    Article  PubMed  Google Scholar 

  15. Partin AW, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA. 1997;277(18):1445–51. PubMed PMID: 9145716. Epub 1997/05/14. eng.

    Article  PubMed  CAS  Google Scholar 

  16. Stephenson AJ, Scardino PT, Eastham JA, Bianco Jr FJ, Dotan ZA, Fearn PA, et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst. 2006;98(10):715–7. PubMed PMID: 16705126. Pubmed Central PMCID: 2242430. Epub 2006/05/18. eng.

    Article  PubMed  Google Scholar 

  17. Heidenreich A, Varga Z, Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol. 2002;167(4):1681–6. PubMed PMID: 11912387. Epub 2002/03/26. eng.

    Article  PubMed  Google Scholar 

  18. Masterson TA, Serio AM, Mulhall JP, Vickers AJ, Eastham JA. Modified technique for neurovascular bundle preservation during radical prostatectomy: association between technique and recovery of erectile function. BJU Int. 2008;101(10):1217–22. PubMed PMID: 18279446. Pubmed Central PMCID: 2568897.

    Article  PubMed  Google Scholar 

  19. Walz J, Graefen M, Huland H. Basic principles of anatomy for optimal surgical treatment of prostate cancer. World J Urol. 2007;25(1):31–8. PubMed PMID: 17333199. Epub 2007/03/03. eng.

    Article  PubMed  Google Scholar 

  20. Walz J, Burnett AL, Costello AJ, Eastham JA, Graefen M, Guillonneau B, et al. A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy. Eur Urol. 2010;57(2):179–92. PubMed PMID: 19931974. Epub 2009/11/26. eng.

    Article  PubMed  Google Scholar 

  21. Canto EI, Nath RK, Slawin KM. Cavermap-assisted sural nerve interposition graft during radical prostatectomy. Urol Clin North Am. 2001;28(4):839–48. PubMed PMID: 11791500.

    Article  PubMed  CAS  Google Scholar 

  22. Secin FP, Koppie TM, Scardino PT, Eastham JA, Patel M, Bianco FJ, et al. Bilateral cavernous nerve interposition grafting during radical retropubic prostatectomy: Memorial Sloan-Kettering Cancer Center experience. J Urol. 2007;177(2):664–8. PubMed PMID: 17222654. Epub 2007/01/16. eng.

    Article  PubMed  Google Scholar 

  23. Ohori M, Scardino PT, Lapin SL, Seale-Hawkins C, Link J, Wheeler TM. The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Am J Surg Path. 1993;17(12):1252–61. PubMed PMID: 8238732.

    Article  PubMed  CAS  Google Scholar 

  24. Licht MR, Klein EA, Tuason L, Levin H. Impact of bladder neck preservation during radical prostatectomy on continence and cancer control. Urology. 1994;44(6):883–7. PubMed PMID: 7527169. Epub 1994/12/01. eng.

    Article  PubMed  CAS  Google Scholar 

  25. Hedican SP, Walsh PC. Postoperative bleeding following radical retropubic prostatectomy. J Urol. 1994;152(4):1181–3. PubMed PMID: 8072090. Epub 1994/10/01. eng.

    PubMed  CAS  Google Scholar 

  26. Vickers AJ, Bianco FJ, Serio AM, Eastham JA, Schrag D, Klein EA, et al. The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst. 2007;99(15):1171–7. PubMed PMID: 17652279. Epub 2007/07/27. eng.

    Article  PubMed  Google Scholar 

  27. Eastham JA, Kattan MW, Rogers E, Goad JR, Ohori M, Boone TB, et al. Risk factors for urinary incontinence after radical prostatectomy. J Urol. 1996;156(5):1707–13. PubMed PMID: 8863576.

    Article  PubMed  CAS  Google Scholar 

  28. Vickers AJ, Bianco FJ, Gonen M, Cronin AM, Eastham JA, Schrag D, et al. Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique. Eur Urol. 2008;53(5):960–6. PubMed PMID: 18207316. Pubmed Central PMCID: 2637145.

    Article  PubMed  Google Scholar 

  29. Vickers A, Savage C, Bianco F, Mulhall J, Sandhu J, Guillonneau B, et al. Cancer control and functional outcomes after radical prostatectomy as markers of surgical quality: analysis of heterogeneity between surgeons at a single cancer center. Eur Urol. 2011;59(3):317–22. PubMed PMID: 21095055. Pubmed Central PMCID: 3060298. Epub 2010/11/26. eng.

    Article  PubMed  Google Scholar 

  30. Augustin H, Hammerer P, Graefen M, Palisaar J, Noldus J, Fernandez S, et al. Intraoperative and perioperative morbidity of contemporary radical retropubic prostatectomy in a consecutive series of 1243 patients: results of a single center between 1999 and 2002. Eur Urol. 2003;43(2):113–8. PubMed PMID: 12565767.

    Article  PubMed  Google Scholar 

  31. Dorin RP, Daneshmand S, Lassoff MA, Cai J, Skinner DG, Lieskovsky G. Long-term outcomes of open radical retropubic prostatectomy for clinically localized prostate cancer in the prostate-specific antigen era. Urology. 2012;79(3):626–31. PubMed PMID: 22245303. Epub 2012/01/17. eng.

    Article  PubMed  Google Scholar 

  32. Kundu SD, Roehl KA, Eggener SE, Antenor JA, Han M, Catalona WJ. Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies. J Urol. 2004;172(6 Pt 1):2227–31. PubMed PMID: 15538237.

    Article  PubMed  Google Scholar 

  33. Lepor H, Kaci L. Contemporary evaluation of operative parameters and complications related to open radical retropubic prostatectomy. Urology. 2003;62(4):702–6. PubMed PMID: 14550447.

    Article  PubMed  Google Scholar 

  34. Lepor H, Nieder AM, Ferrandino MN. Intraoperative and postoperative complications of radical retropubic prostatectomy in a consecutive series of 1,000 cases. J Urol. 2001;166(5):1729–33. PubMed PMID: 11586211.

    Article  PubMed  CAS  Google Scholar 

  35. Lerner SE, Blute ML, Lieber MM, Zincke H. Morbidity of contemporary radical retropubic prostatectomy for localized prostate cancer. Oncology. 1995;9(5):379–82. discussion 82, 85–6, 89. PubMed PMID: 7547200.

    PubMed  CAS  Google Scholar 

  36. Cisek LJ, Walsh PC. Thromboembolic complications following radical retropubic prostatectomy. Influence of external sequential pneumatic compression devices. Urology. 1993;42(4):406–8. PubMed PMID: 8212439.

    Article  PubMed  CAS  Google Scholar 

  37. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 1999;281(17):1591–7. PubMed PMID: 10235151. Epub 1999/05/11. eng.

    Article  PubMed  CAS  Google Scholar 

  38. Bianco Jr FJ, Scardino PT, Eastham JA. Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (“trifecta”). Urology. 2005;66(5 Suppl):83–94. PubMed PMID: 16194712.

    Article  PubMed  Google Scholar 

  39. Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol. 2002;167(2 Pt 1):528–34. PubMed PMID: 11792912.

    PubMed  Google Scholar 

  40. Mullins JK, Feng Z, Trock BJ, Epstein JI, Walsh PC, Loeb S. The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary. J Urol. 2012;188(6):2219–24. PubMed PMID: 23083655. Epub 2012/10/23. eng.

    Article  PubMed  Google Scholar 

  41. Porter CR, Kodama K, Gibbons RP, Correa Jr R, Chun FK, Perrotte P, et al. 25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series. J Urol. 2006;176(2):569–74. PubMed PMID: 16813891. Epub 2006/07/04. eng.

    Article  PubMed  Google Scholar 

  42. Roehl KA, Han M, Ramos CG, Antenor JA, Catalona WJ. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol. 2004;172(3):910–4. PubMed PMID: 15310996.

    Article  PubMed  Google Scholar 

  43. Trapasso JG, deKernion JB, Smith RB, Dorey F. The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. J Urol. 1994;152(5 Pt 2):1821–5. PubMed PMID: 7523728.

    PubMed  CAS  Google Scholar 

  44. Walz J, Joniau S, Chun FK, Isbarn H, Jeldres C, Yossepowitch O, et al. Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy. BJU Int. 2011;107(5):765–70. PubMed PMID: 20875089.

    Article  PubMed  Google Scholar 

  45. Zincke H, Oesterling JE, Blute ML, Bergstralh EJ, Myers RP, Barrett DM. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol. 1994;152(5 Pt 2):1850–7. PubMed PMID: 7523733.

    PubMed  CAS  Google Scholar 

  46. Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol. 2011;185(3):869–75. PubMed PMID: 21239008. Epub 2011/01/18. eng.

    Article  PubMed  Google Scholar 

  47. Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med. 2012;367(3):203–13. PubMed PMID: 22808955. Pubmed Central PMCID: 3429335. Epub 2012/07/20. eng.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter T. Scardino M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Poon, S.A., Scardino, P.T. (2014). Open Radical Retropubic Prostatectomy. In: Eastham, J., Schaeffer, E. (eds) Radical Prostatectomy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8693-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8693-0_7

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8692-3

  • Online ISBN: 978-1-4614-8693-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics